Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.52p
   
  • Change Today:
    -0.085p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,248,667
  • Market Cap: £7.60m
  • RiskGrade: 328
  • Beta: 0.08

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £22,625
Lisa Baderoon 583,963 £8,876
Tim Franklin 525,000 £7,980

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £986,968
Luca & Associates AG 22,000,000 £334,400
Invesco Ltd 17,872,341 £271,660
Aviva Investors Global 11,285,180 £171,535
Alora Pharmaceuticals LLC 10,909,091 £165,818
M&G Investments 7,600,000 £115,520
Prudential plc 7,600,000 £115,520
Capital Income Builder 4,870,367 £74,030
Dr R Zimmer 4,551,553 £69,184
Odey Asset Management 3,433,319 £52,186
Rhone Trustees (Switzerland) SA 3,386,000 £51,467
Pictet Overseas Trust Corporation Limited 3,287,500 £49,970

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.52p
Change Today -0.085p
% Change -5.30 %
52 Week High 5.90
52 Week Low 1.09
Volume 1,248,667
Shares Issued 499.72m
Market Cap £7.60m
Beta 0.08
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.06% below the market average29.06% below the market average29.06% below the market average29.06% below the market average29.06% below the market average
16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average
Price Trend
66.47% below the market average66.47% below the market average66.47% below the market average66.47% below the market average66.47% below the market average
28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 14-Aug-2025

Time Volume / Share Price
16:35 6,523 @ 1.52p
16:35 6,523 @ 1.52p
16:22 59,681 @ 1.51p
16:05 50,000 @ 1.51p
15:59 66 @ 1.55p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page